Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
NCT07172971
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Duchenne Muscular Dystrophy (DMD)
Interventions
DRUG:
SGLT-2 inhibitor
DRUG:
SGLT2 inhibitor
Sponsor
Larry W. Markham
Collaborators
[object Object]